AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Sep 6, 2017
30016_dirs_2017-09-06_0c78bf19-6349-4c92-9870-e2020d54ad7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-09-01
Reporting Person: ESSIG STUART (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-01 | Deferred Stock Unit | $ | A | 240 | Acquired | Common Stock (240) | Direct | |
| 2017-09-01 | Non-Qualified Stock Option (right-to-buy) | $154.98 | A | 2532 | Acquired | 2027-08-31 | Common Stock (2532) | Direct |
Footnotes
F1: This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on July 12, 2017 until the 2018 annual meeting of stockholders.
F2: Each deferred stock unit ('DSU') represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These DSUs will fully vest on the date of the 2018 annual meeting of stockholders or May 3, 2018, whichever event occurs earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.
F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 3, 2018.
F4: Not applicable.